| 2013 ESH/ESC Guidelines for the management of arterial hypertension G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ... Arterial Hypertension 17 (2), 69-168, 2013 | 14107 | 2013 |
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 … Authors/Task Force Members, K Dickstein, A Cohen-Solal, G Filippatos, ... European heart journal 29 (19), 2388-2442, 2008 | 6991 | 2008 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4399 | 2020 |
| Effects of torcetrapib in patients at high risk for coronary events PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ... New England journal of medicine 357 (21), 2109-2122, 2007 | 3706 | 2007 |
| Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ... The Lancet 376 (9744), 875-885, 2010 | 3341 | 2010 |
| Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of … K Swedberg, J Cleland, H Dargie, H Drexler, F Follath, M Komajda, ... European heart journal 26 (11), 1115-1140, 2005 | 2836 | 2005 |
| Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised … PA Poole-Wilson, K Swedberg, JGF Cleland, A Di Lenarda, P Hanrath, ... The Lancet 362 (9377), 7-13, 2003 | 2693 | 2003 |
| The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ... Lancet 353 (9146), 9-13, 1999 | 2433 | 1999 |
| Irbesartan in patients with heart failure and preserved ejection fraction BM Massie, PE Carson, JJ McMurray, M Komajda, R McKelvie, MR Zile, ... New England Journal of Medicine 359 (23), 2456-2467, 2008 | 2384 | 2008 |
| The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis JGF Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, ... European heart journal 24 (5), 442-463, 2003 | 2150 | 2003 |
| Rosuvastatin in older patients with systolic heart failure J Kjekshus, E Apetrei, V Barrios, M Böhm, JGF Cleland, JH Cornel, ... New England Journal of Medicine 357 (22), 2248-2261, 2007 | 2056 | 2007 |
| Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Endorsed by the European Society of Intensive Care Medicine (ESICM), ... European heart journal 26 (4), 384-416, 2005 | 1748 | 2005 |
| Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial PD Home, SJ Pocock, H Beck-Nielsen, PS Curtis, R Gomis, M Hanefeld, ... The Lancet 373 (9681), 2125-2135, 2009 | 1737 | 2009 |
| EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population MS Nieminen, D Brutsaert, K Dickstein, H Drexler, F Follath, VP Harjola, ... European heart journal 27 (22), 2725-2736, 2006 | 1690 | 2006 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1444 | 2011 |
| Sotagliflozin in patients with diabetes and recent worsening heart failure DL Bhatt, M Szarek, PG Steg, CP Cannon, LA Leiter, DK McGuire, ... New England journal of medicine 384 (2), 117-128, 2021 | 1437 | 2021 |
| Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy P Richard, P Charron, L Carrier, C Ledeuil, T Cheav, C Pichereau, ... Circulation 107 (17), 2227-2232, 2003 | 1404 | 2003 |
| Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency P Ponikowski, DJ Van Veldhuisen, J Comin-Colet, G Ertl, M Komajda, ... European heart journal 36 (11), 657-668, 2015 | 1330 | 2015 |
| State of the art: using natriuretic peptide levels in clinical practice A Maisel, C Mueller, K Adams Jr, SD Anker, N Aspromonte, JGF Cleland, ... European journal of heart failure 10 (9), 824-839, 2008 | 1153 | 2008 |
| Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial M Böhm, K Swedberg, M Komajda, JS Borer, I Ford, A Dubost-Brama, ... The Lancet 376 (9744), 886-894, 2010 | 1052 | 2010 |
